clinical study of sustained release cephalexin ( s-6435 and s-6436 ) was conducted with the following results : 1 ) pediatric patients with 1.5 approximately 12 years of age having acute tonsillitis and pharyngitis were orally administered 500 approximately 1,000 mg/day of s-6435 or s-6436 divided into 2 doses after breakfast and dinner .
C0007716
cephalexin
C0031350
pharyngitis